Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The enzyme developer Arzeda has signed an agreement with BP to jointly develop a biobased route to an undisclosed chemical of interest to BP. Seattle-based Arzeda has similar deals with the chemical makers Invista and Mitsubishi Chemical. Separately, Arzeda will work with Labcyte, TeselaGen Biotechnology, and Twist Bioscience to build a DNA assembly platform that reduces the time and cost required to create genes encoding Arzeda’s enzymes.
This article has been sent to the following recipient: